Grants and Contributions:
Title:
Determination of oral efficacy GPS-491 in an animal model of SARS-CoV-2
Agreement Number:
987152
Agreement Value:
$350,816.00
Agreement Date:
Dec 1, 2021 - Feb 29, 2024
Description:
ViroCarb has developed, in collaboration with leading academics in molecular genetics, functional proteomics, and medicinal chemistry, a paradigm-shifting drug platform to stop the replication of multiple viruses, by targeting a cellular function essential for their propagation in cells (RNA processing). Our preclinical drug candidate GPS-491 is highly effective in inhibiting the replication of multiple viruses including SARS-CoV2 and other members of the coronavirus family in human cells. Our goal is to conduct in vivo efficacy studies of our drug candidate in a COVID-19 model of infection in ACE2 transgenic mice, as well as to conduct target validation studies to support the clinical development of a new therapy for COVID-19.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Toronto, Ontario, CA M8V 3Y3
Reference Number:
172-2021-2022-Q4-987152
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
815903208
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 60 days.
Amendment Date
Dec 11, 2023
Recipient's Legal Name:
Virocarb Inc.
Federal Riding Name:
Etobicoke--Lakeshore
Federal Riding Number:
35028
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: